Q103258507
interpellation in the Riksdag from Johan Hultberg to Lena Hallengren, 2020-11-25
Press Enter · cited answer in seconds
0 sources
Q103258507
Summary
Q103258507 is an interpellation[1].
Key Facts
- Q103258507 authored Johan Hultberg[2].
- Q103258507's instance of is recorded as interpellation[3].
- Q103258507's part of the series is recorded as interpellations of the 2020-2021 legislative session of the Riksdag[4].
- Q103258507's language of work or name is recorded as Swedish[5].
- Q103258507 was published on +2020-11-25T00:00:00Z[6].
- Q103258507's significant event is recorded as debate[7].
- Q103258507's main subject is drug[8].
- Q103258507's main subject is medication[9].
- Q103258507's work available at URL is recorded as http://data.riksdagen.se/dokument/H810180[10].
- Q103258507's work available at URL is recorded as http://data.riksdagen.se/dokumentstatus/H810180[11].
- Q103258507's work available at URL is recorded as http://data.riksdagen.se/fil/44669D5E-6520-4C38-86AA-2434C9BE251E[12].
- Q103258507's applies to jurisdiction is recorded as Sweden[13].
- Q103258507's legal citation of this text is recorded as ip. 2020/21:180[14].
- Q103258507's title is recorded as Överförskrivning och missbruk av narkotikaklassade läkemedel[15].
- Q103258507's addressee is recorded as Lena Hallengren[16].
- Q103258507's maintained by WikiProject is recorded as Project Riksdagen's documents[17].
- Q103258507's copyright status is recorded as public domain[18].
Body
Definition and Type
Q103258507's instance of is recorded as interpellation[3].